Perioperative anemia and red blood cell transfusions are important risk factors for morbidity and mortality in cardiac ...
Discusses Updated Long-term Data From Phase 2 BESTOW Clinical Trial in Kidney Transplantation June 22, 2026 8:00 ...
Houston is desperately in need of a reset. But they can use this trade deadline as the springboard to a new era of contention.
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License ...
5don MSN
Doctors Weigh In on Where the NAD+ IV Trend Is Headed, What's in the Bag and Whether It's Worth It
Doctors are weighing in on the pricey NAD+ IV trend now taking over wellness clinics. Here's where this is really headed next ...
5don MSN
People Pay Up to $1,000 for NAD+ IV Drips Trying to Stop Aging, as Interest in Niche Wellness Climbs
People are paying up to $1,000 for NAD+ IV drips hoping to stop aging fast. Here's why interest just keeps climbing in 2026.
Springer Nature is a signatory of the San Francisco Declaration on Research Assessment (DORA). Because small numbers of highly cited articles can have outsized influence on certain citation measures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results